A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
Clinical trial NCT00405743 · COMPLETED
Trial details
- NCT number
- NCT00405743
- Sponsor
- Clavis Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-05-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.